Friday, February 27, 2015 12:44:19 PM
By Joe Duerr on February 27, 2015 Systems & Software Value Analysis
Daktronics, Inc. (NASDAQ:DAKT) has taken a pummeling in recent days after reporting their Q3 earnings at 1 cent per share. With revenue slightly up on the same quarter the year before, and earnings being 1 cent verses 7 cents the prior quarter, the issues appear to be more cost related than anything. As such actual sales growth is not a major issue and perhaps their is still value in this stock after all at these new lows. [Trend Analysis]
Daktronics, Inc. (NASDAQ:DAKT) last traded at $10.24 after moving down -6.99% for the trading day.
DAKT is trading with a trailing 12 month P/E multiple of 21.33 and an estimated forward P/E multiple of 12.60. The stock has an estimated 5 year annual growth of 19.93% and a PEG multiple of 1.07.
From a value investor perspective, as mentioned Daktronics, Inc. trades on an estimated forward P/E multiple of 12.60. The current estimated forward P/E ratio for the market as a whole is approximately 19.82. Therefore, for value investors DAKT appears to be underpriced.
For growth investors, who are more interested in growth into the longer term for the stock, we look at the PEG multiple (P/E to growth) of Daktronics, Inc. (NASDAQ:DAKT). This PEG multiple takes into account the expected long term growth in earnings of Daktronics, Inc. rather than merely the growth for one full earnings period ahead.
As a rule of thumb, growth investors often believe a stock with a PEG of between 0 and 1 is considered to be underpriced, between 1 and 2 to be at fair value and over 2 to be overpriced. Based on the PEG ratio of DAKT being 1.07, we consider Daktronics, Inc. to likely be priced at fair value.
The mean analyst 12 month target price for Daktronics, Inc. (NASDAQ:DAKT) is currently $15.00 or 46.48% above the current price.
Additionally, the stock has been as high as $14.90 and as low as $10.17 in the last 52 weeks. Analysts are estimating that DAKT will report earnings per share of $0.22 next quarter.
_____________________________________
http://www.stockmarketsdaily.com/daktronics-inc-underpriced-nasdaqdakt/10666/
DAKT
Recent DAKT News
- Daktronics to Present at Sidoti Small-Cap Virtual Conference March 13-14 • GlobeNewswire Inc. • 03/08/2024 08:00:29 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/28/2024 03:39:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 03:12:35 PM
- Daktronics, Inc. Announces 2024 Fiscal Third Quarter Results • GlobeNewswire Inc. • 02/28/2024 12:30:00 PM
- Daktronics, Inc. to Release Third Quarter Fiscal 2024 Financial Results • GlobeNewswire Inc. • 02/20/2024 07:10:58 PM
- Daktronics to Present at January 2024 Investor Conferences • GlobeNewswire Inc. • 01/11/2024 09:07:52 PM
- Detroit Tigers Unleash Second-Largest Video Display in Baseball from Daktronics • GlobeNewswire Inc. • 12/15/2023 03:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/05/2023 09:52:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 03:39:28 PM
- Daktronics, Inc. Announces 2024 Fiscal Second Quarter Results • GlobeNewswire Inc. • 12/05/2023 12:30:00 PM
- Daktronics to Present at Singular Research Best of the Uncovered Conference • GlobeNewswire Inc. • 12/01/2023 08:01:21 PM
- Daktronics to Present at Noble Capital Markets’ 19th Annual Emerging Growth Equity Conference • GlobeNewswire Inc. • 11/30/2023 08:26:13 PM
- Daktronics, Inc. to Release Second Quarter Fiscal 2024 Financial Results • GlobeNewswire Inc. • 11/27/2023 09:40:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/18/2023 05:26:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/16/2023 05:12:26 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/11/2023 09:01:37 PM
- Form 11-K - Annual report of employee stock purchase, savings and similar plans • Edgar (US Regulatory) • 10/11/2023 04:34:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/15/2023 04:49:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/13/2023 09:20:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/13/2023 09:15:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/13/2023 09:13:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/13/2023 09:10:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/13/2023 09:09:53 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/13/2023 09:08:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/13/2023 07:53:13 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM